Composition
- Active ingredients
- CEFEPIME HYDROCHLORIDE EQ 2GM BASE/VIAL; ENMETAZOBACTAM 0.5GM/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA216165.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Exblifep
- Active substance
- cefepime hydrochloride
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Orchid Pharma
- Status
- Discontinued
- FDA approval
- 22 Feb 2024
- Application
- NDA216165-001